Medication misuse has resulted in more than 1 million adverse drug events per year in the United States. Patients’ best source (and often only source) of information regarding the medications they have been prescribed is on the prescription container label. Although other written information and oral counseling sometimes may be available, the prescription container label must fulfill the professional obligations of the prescriber and pharmacist. These obligations include giving the patient the most essential information needed to understand how to safely and appropriately use the medication and to adhere to the prescribed medication regimen.
This webinar will cover the definition and purpose of USP Chapter <17> for prescription container labeling standards, an overview of the logic for this chapter, prescription labeling issues, and the relevant state regulations available. Furthermore, it explores the key concepts of USP General Chapter <17> on labeling along with the latest update for this chapter and future directions.
Subject area:
Healthcare Quality & Safety
Objectives (If applicable):
Define the purpose of USP Chapter <17> for prescription container labeling standards
Outline the logic for this chapter & relevant chapters
Explain prescription labeling issues
Identify and describe relevant state regulations
Identify and describe key concepts of USP General Chapter <17> on labeling
Target Audience (If applicable):
– Pharmacists
– Practitioners
– Pharmacy software vendors
– State board of pharmacy personnel
– Consumer advocate